Increased C5a receptor expression in sepsis

• Published in: The Journal of clinical investigation Vol. 110; no. 1; pp. 101 - 108
• Main Authors: Riedemann, Niels C, Guo, Ren-Feng, Neff, Thomas A, Laudes, Ines J, Keller, Katie A, Sarma, Vidya J, Markiewski, Maciej M, Mastellos, Dimitrios, Strey, Christoph W, Pierson, Carl L, Lambris, John D, Zetoune, Firas S, Ward, Peter A
• Format: Journal Article
• Language: English
• Published: United States American Society for Clinical Investigation 01-07-2002
• Subjects: Abdomen; Animals; Antibodies; Antibodies - administration & dosage; Antigens, CD - genetics; Antigens, CD - metabolism; Biomedical research; Cytokines; Disease Models, Animal; Immunization; Immunohistochemistry; Ketamine; Kidney - immunology; Laboratories; Liver; Liver - immunology; Lung - immunology; Lungs; Lymphocyte Depletion; Male; Mice; Mice, Inbred BALB C; Myocardium - immunology; Neutrophils; Neutrophils - immunology; Peptides; Pulmonary arteries; Receptor, Anaphylatoxin C5a; Receptors, Complement - antagonists & inhibitors; Receptors, Complement - genetics; Receptors, Complement - metabolism; RNA, Messenger - genetics; RNA, Messenger - metabolism; Sepsis; Sepsis - genetics; Sepsis - immunology; Sepsis - prevention & control; Tissue Distribution; Up-Regulation; United States > US; New Jersey
• ISSN: 0021-9738; 1558-8238
• DOI: 10.1172/JCI0215409

Excessive production of the complement activation product C5a appears to be harmful during the development of sepsis in rodents. Little is known about the role of the C5a receptor (C5aR) and its presence in different organs during sepsis. Using the cecal ligation/puncture (CLP) model in mice, we show here that C5aR immunoreactivity was strikingly increased in lung, liver, kidney, and heart early in sepsis in both control and neutrophil-depleted mice. C5aR mRNA expression in these organs was also significantly increased during sepsis. Immunohistochemical analysis revealed patterns of increased C5aR expression in parenchymal cells in all four organs following CLP. Mice injected at the start of CLP with a blocking IgG to C5aR (alphaC5aR) showed dramatically improved survival when compared with animals receiving nonspecific IgG, as did mice injected with alphaC5a. In alphaC5aR-treated mice, serum levels of IL-6 and TNF-alpha and bacterial counts in various organs were significantly reduced during CLP when compared with control CLP animals. These studies demonstrate for the first time that C5aR is upregulated in lung, liver, kidney, and heart during the early phases of sepsis and that blockade of C5aR is highly protective from the lethal outcome of sepsis.